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Novelty processingPrevious studies have shown that in amyotrophic lateral sclerosis (ALS) multiplemotor and extra-motor regions
display structural and functional alterations. However, their temporal dynamics during disease-progression are
unknown. To address this question we employed a longitudinal design assessing motor- and novelty-related
brain activity in two fMRI sessions separated by a 3-month interval. In each session, patients and controls execut-
ed a Go/NoGo-task, in which additional presentation of novel stimuli served to elicit hippocampal activity. We
observed a decline in the patients3movement-related activity during the 3-month interval. Importantly, in com-
parison to controls, the patients3motor activationswere higher during the initial measurement. Thus, the relative
decrease seems to reﬂect a breakdown of compensatory mechanisms due to progressive neural loss within the
motor-system. In contrast, the patients3 novelty-evoked hippocampal activity increased across 3 months, most
likely reﬂecting the build-up of compensatory processes typically observed at the beginning of lesions. Consistent
with a stage-dependent emergence of hippocampal and motor-system lesions, we observed a positive correla-
tion between the ALSFRS-R or MRC-Megascores and the decline in motor activity, but a negative one with the
hippocampal activation-increase. Finally, to determine whether the observed functional changes co-occur with
structural alterations, we performed voxel-based volumetric analyses onmagnetization transfer images in a sep-
arate patient cohort studied cross-sectionally at another scanning site. Therein, we observed a close overlap be-
tween the structural changes in this cohort, and the functional alterations in the other. Thus, our results provide
important insights into the temporal dynamics of functional alterations during disease-progression, and provide
support for an anatomical relationship between functional and structural cerebral changes in ALS.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disor-
der characterized by progressive muscular weakness and atrophy.
Although the degeneration of upper and lower motor neurons is
the pathological hallmark of the disease, several studies indicated
that ALS is a multisystem disorder that also affects cognitive domainsStoppel).
ry and Psychotherapy, Charité -
ermany.
. This is an open access article under(Agosta et al., 2010; Raaphorst et al., 2010; Tsermentseli et al., 2012).
Concordantly, neurodegenerative changes beyond the motor-system
have been reported (Anderson et al., 1995; Grosskreutz et al., 2006;
Kato et al., 1997; Neumann et al., 2006; Takeda et al., 2009; Wightman
et al., 1992).
Besides such structural changes, functional alterations related to ALS
have also been observed acrossmultiplemotor and extra-motor regions
using a variety of different tasks (for recent review see Tsermentseli et al.,
2012). Most studies observed increased activations of sensorimotor areas
and/or recruitment of additional regions, which was interpreted as func-
tional compensation or reorganization within the motor-system (Kew
et al., 1993; Kollewe et al., 2011; Konrad et al., 2002; Mohammadi et al.,
2011; Schoenfeld et al., 2005). However, some studies also found an acti-
vation decrease of sensorimotor and premotor areas (Mohammadi et al.,the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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ﬁndings refers to the heterogeneity of the patient populations especially
with regard to their particular disease stage during the time of study.
Bearing this inmind, it is important to note that neurodegenerative alter-
ations and therewith—interrelated functional loss or compensatory pro-
cesses are certainly subject to change during progression of the disease.
Thus, to identify patterns of functional alterations and their putativemod-
iﬁcations during ALS disease-progression, it is indispensable to perform
longitudinal within-subject investigations. The present study was de-
signed to directly address such progression-related functional changes
in motor and cognitive functions. To this end, brain activity in fourteen
ALS patients and fourteen healthy controls was studied in two fMRI ses-
sions separated by a 3-month interval, employing a simple Go/NoGo-
task, in which the additional presentation of task-irrelevant novel stimuli
allowed for assessment of novelty-related hippocampal activity.
In addition, to assess the relationship between functional and struc-
tural changes emerging during ALS disease-progression, we performed
cross-sectional voxel-basedmorphometric (VBM) analyses on structur-
al volumes acquired with magnetization transfer imaging in an inde-
pendent, but socio-demographically comparable sample of 26 ALS
patients and 28 controls. The magnetization transfer ratio of tissues
depends on the surface chemistry and biophysical dynamics of macro-
molecules, as well as their tissue concentration (Cosottini et al., 2011;
Eckert et al., 2004; Kato et al., 1997; Muller-Vahl et al., 2009; Wolff
and Balaban, 1994). As such it has been shown to be strongly associated
with tissue integrity (Grossman et al., 1994) and reducedmagnetization
transfer ratios have therefore repeatedly been suggested to mirror
microstructural alterations like gliosis and changes in axonal density
possibly related to early-stage neurodegenerative phenomena (Eckert
et al., 2004; Kiefer et al., 2009; Perez-Torres et al., 2014; Ridha et al.,
2007).
2. Materials and methods
2.1. Subjects
Two patient samples with sporadic ALS were recruited from the ALS
outpatient clinics of thedepartments of Neurology at theMedical School
Hannover and at theMedical School of the Otto-von-Guericke Universi-
tyMagdeburg. All patientsmet the criteria for probable or deﬁnitive ALS
as deﬁned by the El Escorial diagnostic criteria for ALS (Brooks et al.,
2000) and had either a limb or bulbar onset. Exclusion criteria were
other neurological conditions that could affect motor performance and
cognition (e.g. stroke, traumatic brain injury). The ﬁrst sample of four-
teen patients took part in the fMRI experiment. The second sample of
twenty-six patients participated in the VBM study. All participants
underwent clinical examination on the day of study with active follow-
up. Disease severity was assessed using the revised ALS Functional RatingTable 1
Participant demographics and clinical features.
VBM study
ALS patients Healthy co
Gender (M/F) 13/13 13
Age (years) 60.4 ± 2.2a,c (30-86) 60.1 ± 1.9
Disease duration (months) 23.8 ± 4.8(6–120) N
Site of onset (spinal/bulbar) 22/4 N
ALSFRS-R 36.2 ± 1.2(20-46) N
MRC-Megascore NA N
Rate of disease-progression 0.74 ± 0.09 (0.13–2.0) N
Data for the subjects3 age, disease duration, ALSFRS-R, MRC-Megascore, and the rate of disease-p
revised ALS Functional Rating Scale; MRC, Medical Research Council.
Two-sample t-tests
a T(1,52) = 0.08, p N 0.9;
b T(1,26) = 1.45, p N 0.1;
c T(1,38) = 0.02, p N 0.9;
d T(1,40) = 1.79, p N 0.1.Scale (ALSFRS-R; Cedarbaum et al., 1999). Disease duration was deﬁned
as time in months between symptom onset and the date of the experi-
ment. From these measures the disease-progression rate was then calcu-
lated as (48− ALSFRS-R)/disease duration (Ellis et al., 1999). In addition,
the neuromuscular impairment was quantiﬁed by the ﬁve-point Medical
Research Council (MRC) scale. 15 muscles were tested on the right and
left for a maximum score of 150 (sternocleidomastoids, shoulder ab-
ductors and adductors, elbow ﬂexors and extensors, wrist ﬂexors
and extensors, long ﬁnger ﬂexors, thumb opponent, ﬁnger abductors
and adductors, hip ﬂexors, knee ﬂexors and extensors, and ankle
dorsiﬂexors). Good reliability and reproducibility for manual muscle
testing in patients with ALS have previously been shown (Great lakes
ALS Study Group, 2003; Andres et al., 1988). Furthermore, a detailed
neuropsychological assessment lasting about 2 hwas performed during
the baseline visit in the ﬁrst sample of fourteen patients who took part
in the fMRI experiment.
Forty-two healthy individuals similar to the patients in age and gen-
der were recruited as controls. Twenty-eight of the subjects were in-
cluded in the VBM study and the remaining fourteen took part in the
fMRI experiment. Ethical approval for all procedures was obtained
prior to study (Vote number 11/06-75/11, Ethical committee of the
Medical Faculty of the Otto-von-Guericke University, Magdeburg) and
all participants gave written informed consent before participation. All
experimental procedures have been performed in accordance with the
ethical standards laid down in the 1964 Declaration of Helsinki and its
later amendments.
Subject demographics and all relevant clinical data are shown in
Table 1.2.2. Neuropsychological assessment
For neuropsychological assessment a range of standardized neuro-
psychological tests were employed (see Table 2). Verbal memory per-
formance was tested using the VLMT, a German version of the Rey
Auditory Verbal Learning Task (Lezak et al., 2004), and non-verbal
memory using the Rey Complex Figure Test (Shin et al., 2006). Further-
more, we measured the Digit Span and the Visual Memory Span (Lezak
et al., 2004). To address executive frontal functions, the Ruff Figural Flu-
ency Test (Ruff et al., 1987), the Trail-making Test (Soukup et al., 1998),
the Regensburger Verbal Fluency Test (Aschenbrenner et al., 2000), and
the copy subtest of the Rey Complex Figure Test were employed. Atten-
tionwas assessed using the d2 attention test (Brickenkamp and Zillmer,
1998). Deﬁcient verbal memory performance was deﬁned as abnormal
performance (b2 standard deviations compared to an age matched ref-
erence population) in ≥2 different memory tasks (Phukan et al., 2012).
Executive dysfunction was deﬁned as an abnormal performance in ≥2
different executive tests (Strong et al., 2009). Adjustments were madefMRI experiment
ntrols ALS patients Healthy controls
/15 13/1 13/1
a,d (33-78) 60.3 ± 3.1b,c (39-76) 59.7 ± 3.3b,d (42-79)
A 18.3 ± 3.1 (6-49) NA
A 11/3 NA
A 38.2 ± 1.3 (26-44) NA
A 130.9 ± 5.1 (79-150) NA
A 0.66 ± 0.09 (0.22–1.5) NA
rogression are presented asmean± standard error of themean. Abbreviations: ALSFRS-R,
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Fluency Test, and Trail-making Test).
The patients3 neuropsychological data are summarized in Table 2.
Based on the classiﬁcation scheme suggested by Phukan et al. (2012),
14% of the patients showed executive dysfunction (ALS-Ex, single do-
main), 21% had executive paired with memory dysfunction, attention
dysfunction or impaired visuo-construction (ALS-Ex, multi domain) and
7% showed deﬁcits regarding attentional performance (non-executive
impairment, ALS-NECI). 58% of the ALS patients had no cognitive impair-
ment. None of the patients fulﬁlled the Neary criteria for frontotemporal
dementia (Neary et al., 1998).2.3. MRI data acquisition
2.3.1. fMRI data acquisition
Data were acquired on a 3-Tesla MR scanner (Siemens Magnetom
Trio, Erlangen, Germany) equipped with an 8-channel head coil. The
subjects viewed the stimuli through a mirror attached to the head coil,
which reﬂected the images thatwere back-projected from an LCD projec-
tor onto a screenpositioned behind the coil. During each run 187 volumes
were acquired with a T2×-weighted echo planar imaging sequence (32
AC-PC oriented slices, TR 2000 ms, TE 30 ms, ﬂip-angle 80°, in-plane res-
olution 64 × 64 mm2, FoV 224 × 224 mm2, no gap, resulting voxel-size
3.5 × 3.5 × 3.5 mm3) in an odd–even interleaved sequence. Scanning pa-
rameters as well as the paradigm were the same for both scanning ses-
sions separated by a 3-month interval.Table 2
Neuropsychological data of the ALS patients.
Test Parameter Mean scores (SD
1. Learning and memory
VLMT
Supra span D1 # words 5,7 (1,3)
Learning D5 # words 11,6 (1,6)
Total learning∑ D1− D5 # words 45,1 (6,6)
Interference # words 5,5 (1,2)
Immediate verbal recall (D6) # words 8,8 (2,9)
Delayed verbal recall (D7) # words 9,4 (2,5)
Rey complex ﬁgure test
Immediate visual recall Points 17,1 (4,1)
Delayed visual recall Points 17,0 (3,9)
Digit span
Forwards Raw-values 7,4 (2,4)
Backwards Raw-values 6,4 (1,8)
Visual memory span
Forwards Raw-values 7,8 (2,4)
Backwards Raw-values 7,2 (1,2)
2. Executive functions
Verbal Fluency (RWT)
Phonematic ﬂuidity # words 15,4 (6,4)
Phonematic ﬂexibility # words 14 (6,1)
Semantic ﬂuidity # words 32,4 (8,3)
Semantic ﬂexibility # words 20,7 (3,2)
Ruff ﬁgural ﬂuency
Unique designs Raw-values 69,6 (17,9)
Perseverative errors Raw-values 4,0 (4,4)
Rey complex ﬁgure test
Copy Points 33,6 (2,0)
Trail-making-test
A seconds 37,7 (14,5)
B seconds 98,9 (45,1)
Ratio B/A # 2,8 (0,9)
3. Attention
d2
Total number of items Raw-values 349,8 (81,8)
Errors Raw-values 19,3 (12,2)
Corrected performance Raw-values 330,5 (75,3)
Concentration performance Raw-values 124,7 (12,2)
a At or below the 10th percentile.
b Number of patients that completed the respective test/subtest.2.3.2. Image acquisition for VBM analysis
Structural images for the VBM analysis were acquired on a 1.5-T GE,
Signa Horizon LX scanner equipped with a standard quadrature head
coil (General Electric, Milwaukee, WI, USA). The protocol for magnetiza-
tion transfer imaging consisted of a proton-densityweighted SE sequence
(48AC–PC oriented slices, TR=2600ms, TE=20ms, in-plane resolution
256 × 256 mm2, resulting voxel-size = 3 × 1 × 1 mm3) both with (MT)
and without (PD) a preparing saturation pulse (1200 Hz off-resonance,
1180° ﬂip angle, 16 ms). Image post-processing included an inter-
sequencemovement correction by co-registration of theMT and PD im-
ages and subsequent calculation of the magnetization transfer ratio
maps (MTR) by the formula MTR = 100 × [(PD−MT)/PD].2.4. Experimental design
The fMRI experiment consisted of two scanning sessions separated
by a 3-month interval, in both of which functional data were acquired
in 4 runs of 6 min each, while subjects performed in a modiﬁed Go/
NoGo-paradigm. All subjects (14 patients and their respective controls)
participating in the fMRI experiment were scanned twice. The mean in-
terval between sessions was 95 ± 10 (standard deviation; SD) days
(range: 77–112 days) for the patients and 86 ± 10 (SD) days (range:
71–116 days) for controls. During the task subjects were repeatedly
presented with a target (church with 3 towers) and a highly similar
non-target stimulus (church with only 2 towers, see Fig. 1), with
which they were familiarized before the experiment. Subjects were) Patients within deﬁcient rangea Number of patientsb
1/14 (7%) 14
1/14 (7%) 14
2/14 (14%) 14
2/14 (14%) 14
3/14 (21%) 14
2/14 (14%) 14
1/13 (8%) 13
1/13 (8%) 13
3/14 (21%) 14
2/14 (14%) 14
4/13 (30%) 13
0/13 (0%) 13
4/14 (29%) 14
5/14 (36%) 14
2/14 (14%) 14
1/14 (7%) 14
2/11 (18%) 11
1/11 (9%) 11
1/14 (7%) 14
2/14 (14%) 14
1/14 (7%) 14
6/14 (43%) 14
5/12 (42%) 12
0/12 (0%) 12
5/12 (42%) 12
4/12 (33%) 12
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of the target, but not to the highly similar non-target stimulus. In addi-
tion, our design included the presentation of novel stimuli (indoor and
outdoor black-and-white pictures), each of which was presented only
once throughout the experiment. The total number of novel pictures
matched the number of repetitions of the target and non-target stimuli
(176 presentations throughout each scanning session).
Target and non-target stimuli were identical across sessions for all
participants, while novel stimuli differed across sessions. In addition,
to avoidmemory/habituation-effects, pictures of outdoor-scenes served
as novels within one and indoor-scenes in the other fMRI session
(counterbalanced across subjects). All stimuli (size of 9.6 × 5.8°)
were presented 4.4° above a central ﬁxation cross for 1 s and their
presentation-sequence was pseudo-randomized with an inter-trial in-
terval varying between 2 and 6 s (mean: 2.75 s) to allow for trial sepa-
ration in an event-related analysis.
2.5. fMRI data analysis
fMRI data were analyzed using SPM8 software (Wellcome De-
partment of Cognitive Neurology, University College London, UK)
and MATLAB 7.9 (The MathWorks Inc.). Functional data from both
measurements were slice-time corrected and realigned. Then the mean
image derived from realignment of the 2nd session was co-registered
to that of the 1st session and the resultant spatial transformation matri-
ces were applied to all volumes of the 2nd session. Finally, all images
were spatially normalized to an EPI template inMNI space and smoothed
with an isotropic Gaussian kernel of 8-mm full-width at half-maximum.
For statistical analysis, blood-oxygen level-dependent responses were
modeled by delta functions at the time of stimulus onsets. Resultant
event-regressors (Targets, Non-Targets, and Novels) were entered into aTarget
Non-
Targe
Novel
Fig. 1. Schematic illustration of the experimental design. The paradigm consisted of a modiﬁed
stimulus, the design also included the presentation of novel pictures (each of which occurr
button-press response upon detection of the target picture, but to withhold their response to tgeneral linear model and convolved with the standard hemodynamic-
response function implemented in SPM8. Movement parameters from
the realignment procedure were included as covariates into the
model. The data from both scanning sessions were independently
analyzed, resulting in two contrasts of interest per session and sub-
ject (“Targets N Non-Targets” and “Novels N Non-Targets”). These
individual-subject contrasts then were submitted to second-level
random-effects group analyses (one-sample t-tests). In addition,
session-speciﬁc contrasts were directly compared against each other by
second-level paired t-tests to identify activity changes within 3 months
of ALS disease-progression.
All statistical parametric maps from the group analyses were
thresholded at p b 0.001 (uncorrected) for voxel-level inference
with a minimum cluster-size criterion of 20 contiguous voxels, and
subsequent cluster-level correction for multiple testing at p b 0.05
(FWE-corrected). Given our a priori hypotheses, the signiﬁcance of
activated clusters in the primary motor cortex, cerebellum, and hip-
pocampus, was assessed using small volume correction (SVC). Statis-
tical parametric maps were visualized using MRIcron (http://www.
mccauslandcenter.sc.edu/mricro/mricron/).
To directly compare the magnitude of motor- and novelty-related
modulations between sessions, and for correlation of activation differ-
ences with clinical measures, a region of interest (ROI) analysis
was performed using MarsBar (Brett et al., 2002). Functional ROIs
located in the left primary motor cortex (M1), bilateral cerebellum,
and bilateral hippocampus were deﬁned based on the signiﬁcant
clusters obtained from the second-level paired t-test group analyses
on the patients3 data. Beta-estimates for the contrasts “Targets N Non-
Targets” and “Novels N Non-Targets” were extracted from both fMRI
measurements. These values were submitted to repeated-measures
ANOVAs (RANOVA)with the factor contrast (“Targets N Non-Targets”t
Novel
Novel
Go/NoGo-task. Beyond repeated presentation of a target and a highly similar non-target
ed only once during the entire experiment). The subjects3 task was to make a speeded
he highly similar non-target and novel stimuli.
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signiﬁcance (p b 0.05) was obtained, paired t-tests were applied
for post hoc comparison. If signiﬁcant differences in motor- or
novelty-related activity across sessions were observed, correlations
between these difference values and the patients3 clinical parameters
(ALSFRS-R and MRC-Megascore) were assessed by Spearman3s rank
correlation.
To relate the patients3motor- and novelty-evoked activations to those
of healthy individuals, mean contrast-estimates from the left M1 and bi-
lateral hippocampus were also extracted from the control subjects3 data.
Analysis of the resultant hippocampal data by RANOVA (within-subject
factor hemisphere and session, between-subject factor group) revealed
no main effects or interactions for the factor hemisphere. Therefore,
data of both hippocampal ROIs were collapsed. The resultant values
then were analyzed by RANOVA with the within-subject factor session
and the between-subject factor group. If signiﬁcant effects (p b 0.05)
were obtained, paired t-tests (within-subject comparison) or two-
sample t-tests (comparison between groups) were applied for post
hoc analysis.Table 3
Behavioral data from the fMRI experiment.
ALS patients Healthy controls
1st session 2nd session 1st session 2nd session
Reaction times [ms] 629 ± 27 619 ± 21 577 ± 16 575 ± 18
Correct responses [%] 99.2 ± 0.3 98.7 ± 0.5 98.9 ± 0.6 97.1 ± 1.5
False alarms [%] 0.7 ± 0.2 0.5 ± 0.2 0.9 ± 0.2 0.5 ± 0.1
All data denote the mean ± standard error of the mean.2.6. VBM data analysis
In contrast to the fMRI experiment, MTR data from our second cohort
were acquired only once. These data thus only allowed for a cross-
sectional comparison between patients and controls, but not for assess-
ment of longitudinal structural changes emerging during ALS disease-
progression. The VBM analysis on MTR data was also performed using
SPM8. First, PD-weighted images from 52 healthy, aged individuals
(which did not serve as control subjects in the current study)were nor-
malized to the PD-template included in SPM8. The resulting normaliza-
tion parameters were applied to the concurrently acquired MT-images
of the 52 subjects. Then the normalized MT-volumes were smoothed
with a 4-mm FWHM isotropic Gaussian kernel and averaged to create
a scanner-speciﬁc template for normalization of our current VBM
data. MT-images of our ALS patients and their respective controls
were normalized to this template and the resultant normalization pa-
rameters were applied to the inherently co-registered MTR-maps. Final-
ly, these normalized MTR-volumes were smoothed with an isotropic
Gaussian kernel of 4 mm FWHM.
For statistical analysis the normalized and smoothed MTR-images
were submitted to an ANCOVA with study group (ALS patients vs. con-
trols) as themain factor, and age, aswell as total brain volume as covar-
iates. Directional t-contrasts were deﬁned between groups, whereby
only the contrast “Controls N ALS patients” revealed signiﬁcant effects.
To assess putative correlations between the disease-related structural
changes and the patients3 clinical data we performed regression analy-
ses on the patients3 MTR volumes by adding the their clinical data into
the design as covariates (ALSFRS-R scores, MRC-Megascores, disease
duration and disease progression rate), in addition to their age and
total brain volumes. Beyond that, spherical ROIs (4 mm radius) were
centered at the local maxima showing signiﬁcant MTR differences be-
tween patients and controls in the main ANCOVA (see Table 6 for
MNI-coordinates of these local maxima where ROIs were centered).
From these ROIsmeanMTR-values were extracted and then correlat-
ed with the patients3 ALSFRS-R scores, MRC-Megascores, their
disease duration and disease progression rate using Spearman3s
rank correlation.
For the SPM analyses, stereotactic coordinates for voxels with
maximum t-values within signiﬁcant activation clusters are reported
in MNI standard space using an auxiliary voxel-level threshold
of p b 0.001 (uncorrected) with a minimum cluster-size criterion of
50 contiguous voxels and subsequent cluster-level correction for
multiple testing at p b 0.05 (FWE-corrected). Data were visualized
using the MRIcron software package (http://www.mccauslandcenter.sc.
edu/mricro/mricron/).3. Results
3.1. Behavioral results
Reaction times, correct responses and false alarms (see Table 3) were
analyzed by RANOVAs with the within-subject factor session and the
between-subject factor group. These analyses revealed no signiﬁcant
main effects or interactions neither for the reaction times (session:
F(1,26) = 0.6, p N 0.4; group: F(1,26) = 2.9, p = 0.1; group × session:
F(1,26) = 0.2, p N 0.6), nor for the correct responses (session:
F(1,26) = 1.8, p N 0.1; group: F(1,26) = 1.1, p N 0.2; group × session:
F(1,26) = 0.6, p N 0.4), or for the false alarm rates (session: F(1,26) =
2.9, p = 0.1; group: F(1,26) = 0.2, p N 0.6; group × session: F(1,26) =
0.3, p N 0.5) of the study participants. Direct comparison across sessions
(paired t-tests) also showed no signiﬁcant differences for any of the
behavioral measures of the patients (reaction times: T(1,13) = 0.8,
p N 0.4; correct responses: T(1,13) = 1.1, p N 0.2; false alarms:
T(1,13) = 0.8, p N 0.4), or controls (reaction times: T(1,13) = 0.2,
p N 0.8; correct responses: T(1,13) = 1.1, p N 0.2; false alarms:
T(1,13) = 1.6, p N 0.1). Taken together, the behavioral data showed no
signiﬁcant differences between patients and controls and also no signiﬁ-
cant alterations over scanning sessions within each of the two groups.
3.2. fMRI results
For the healthy controls we observed no differences in motor- or
novelty-related activity across sessions (data not shown).
3.2.1. Motor-related activations in ALS patients
The “Targets N Non-Targets” contrasts from both sessions revealed
activity in a variety of regions associatedwith themotor-system, includ-
ing the bilateral primary motor cortex (M1), bilateral cerebellum, sup-
plementary motor area, bilateral inferior frontal gyrus/ anterior insula,
striatum, and portions of the thalamus (see Fig. 2A, as well as the
upper and middle rows of Table 4). Note that maximum t-values and
cluster-sizes of these activations are considerably higher during the
1st than during the 2nd session, indicative of a decrease in motor-
related activity across sessions. This assumption was validated by a
paired t-test showing that motor-related activity in the left M1 and bi-
lateral cerebellum was in fact signiﬁcantly higher during the 1st than
during the 2nd measurement (see Fig. 2B and bottom rows of Table 4).
To further corroborate this ﬁnding, contrast-estimates from ROIs
located in the left M1 and bilateral hippocampus were subjected to
RANOVAs with the factor contrast and session. These analyses showed
a signiﬁcant main effect for the factor contrast for the left M1
(F(1,13) = 37.8, p b 0.0001) and the left cerebellum (F(1,13) = 5.5,
p b 0.05), as well as a signiﬁcant contrast × session interaction for all
3 ROIs (left M1: F(1,13) = 32.9, p b 0.0001; left cerebellum: F(1,13) =
8.5, p b 0.05; right cerebellum: F(1,13) = 25.7, p b 0.001). Post hoc com-
parisons indicated that these effects were due to higher estimates for the
contrast “Targets NNon-Targets” of the 1st in comparison to the 2ndmea-
surement (see Fig. 2B; left M1: T(1,13) = 5.2, p b 0.001; left cerebellum:
T(1,13) = 3.7, p b 0.005; right cerebellum: T(1,13) = 4.9, p b 0.001).
To investigate the relationship between the activation decrease
within 3months of disease-progression and the patients3 clinical status,
we correlated themagnitude of the activity reductionwith the patients3
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Fig. 2. Functional changes inmotor regions related to ALS disease-progression. A) Motor activity (“Targets N Non-Targets”) from the 1st and 2nd fMRI sessions. Motor-related activations
were observed in the bilateral primary motor cortex, cerebellum, inferior frontal gyrus/ anterior insula, striatum, thalamus, and in the supplementary motor area. Note that maximum
t-values and the extent of activations are considerably higher for the 1st than for the 2nd session. B) Direct comparison of motor-related activity across sessions. A decrease in motor-
related activity from the 1st to the 2nd measurement was evident in the left primary motor cortex and bilateral cerebellum, which was conﬁrmed in a ROI-analysis (see bar graphs).
C) Correlation of ROI-results and the patients3 clinical data. The decrease in motor-related activity correlated with the patients3 ALSFRS-R scores for both cerebellar ROIs, while in the
primary motor cortex it correlated with their MRC-Megascores.
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signiﬁcant correlation between the motor-related activation de-
crease and the patients3 ALSFRS-R scores for both cerebellar ROIs
(left cerebellum: ρ = 0.60, p b 0.05; right cerebellum: ρ = 0.54,
p b 0.05), and with the patients3 MRC-Megascores for the left M1
(ρ = 0.61, p b 0.05).
3.2.2. Novelty-related activations in ALS patients
For both sessions, the comparison “Novels N Non-Targets” showed ac-
tivationswithinmultiple ventral occipital and temporal regions, including
themiddle/superior occipital, fusiform, lingual and parahippocampal gyri
(see Fig. 3A and upper/middle rows of Table 5). In addition, stimulus nov-
elty signiﬁcantly activated the bilateral hippocampus, but due to thechosen threshold of p b 0.001 only during the 2nd measurement. Direct
comparison between sessions conﬁrmed that in the bilateral hippocam-
pus the novelty-related activity was higher during the 2nd in comparison
to the 1st session (Fig. 3B; bottom rows of Table 5).
Direct comparison of these activation changes by RANOVAs with the
factor contrast and session for the bilateral hippocampal ROI data showed
a signiﬁcant main effect for the factor contrast (left hippocampus:
F(1,13) = 11.5, p b 0.005; right hippocampus: F(1,13) = 41.3, p b 0.05)
and a signiﬁcant contrast-by-session interaction (left hippocampus:
F(1,13) = 6.7, p b 0.05; right hippocampus: F(1,13) = 8.2, p b 0.05).
Post hoc comparisons revealed that these interactionswere due to higher
novelty-related activity during the 2nd in comparison to the 1st ses-
sion (see Fig. 3B; left hippocampus: T(1,13) = 5.0, p b 0.001; right
Table 4
Peak activation foci for the comparisons of Targets N Non-Targets.
Anatomical structure Hemisphere MNI coordinates (x,y,z) Max.
t-value
FWE-corrected cluster p-value Cluster size
Targets N Non-Targets — 1st session
Anterior insula L –52 6 2 16.34 b0.001 11,389
R 56 10 14 16.19
IFG L –58 10 36 11.63
R 52 6 38 13.32
Thalamus L –14 –14 2 12.78
R 6 –12 4 8.60
SMG/Pre- / postcentral gyrus L –54 –34 36 11.90
STN L –10 –20 –6 11.37
Precentral gyrus L –48 –24 54 10.95
Striatum L –20 2 –2 9.73
R 20 8 8 10.42
Cerebellum L –34 –54 –32 11.47 b0.001 4303
R 34 –52 –28 15.08
SMA − 2 –2 56 11.52 b0.001 1180
SMG/Pre- / postcentral gyrus R 56 –22 –40 10.32 b0.001 2356
Cuneus − 0 –92 14 7.63 b0.001 389
Targets N Non-Targets — 2nd session
Anterior insula L –36 4 4 11.66 b0.001 2750
IFG L –56 12 24 8.33
Striatum L –16 6 –2 7.03
Thalamus L –14 –20 4 8.36
SMG/ pre-/ postcentral gyrus L –48 –36 28 9.76 b0.001 2067
Anterior insula R 36 2 –6 8.39 b0.001 597
Cerebellum R 20 –48 –24 8.33 b0.001 909
SMA − –10 –8 56 8.05 b0.001 274
SMG/ pre-/ postcentral gyrus R 60 –38 44 6.68 b0.001 266
Cerebellum L –30 –56 –30 6.31 b0.05 77
Striatum R 16 6 2 5.99 b0.05 89
(Targets N Non-Targets — 1st session) N (Targets N Non-Targets — 2nd session)
Lingual gyrus L –10 –62 –6 8.11 b0.001 5769
R 10 –66 –4 5.05
Calcarine L –10 –72 8 6.70
R 8 –78 8 5.83
Cuneus L –10 –96 30 5.25
R 12 –94 26 6.15
Cerebellum R 28 –58 –18 4.70
Precentral gyrus L –30 –24 42 5.27 b0.01 (SVC) 387
Cerebellum L –30 –52 –26 4.20 b0.05 (SVC) 57
Thalamus L –10 –20 6 4.46 b0.05 (SVC) 130
R 16 –20 8 4.53 b0.05 (SVC) 159
Striatum L –12 8 –2 3.47 b0.05 (SVC) 48
R 10 12 –4 4.03 b0.05 (SVC) 91
Abbreviations: IPS, intraparietal sulcus; MOG, middle occipital gyrus; PHG, parahippocampal gyrus; SOG, superior occipital gyrus; SVC, small-volume correction.
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activation differences showed a negative correlation with the patients3
ALSFRS-R scores for both hippocampal ROIs (see Fig. 3C for graphical il-
lustration; left hippocampus: ρ=−0.60, p b 0.05; right hippocampus:
ρ=−0.63, p b 0.05).
3.2.3. Motor- and novelty-related activations in patients relative to controls
The within-subject analyses presented so far revealed a decrease of
motor-related and an increase of novelty-evoked activity in patients
during the 3-month interval. These data on their own, however, did
not allow inferring about the relative course of these changes compared
to functionally intact neural activations. To overcome this limitation,
beta-estimates from the ROIs covering the left M1 and bilateral hippo-
campus were also extracted from the control subjects3 functional data
and compared to those of the patients3.
For both the hippocampal andmotor-related activations analyses by
RANOVAS revealed a signiﬁcant main effect for the factor session (left
M1: F(1,26) = 8.8; p b 0.01; hippocampus: F(1,26) = 11.6; p b 0.005)
and a group-by-session interaction (left M1: F(1,26) = 4.4; p b 0.05;
hippocampus: F(1,26) = 4.6; p b 0.05). For the left M1, post hoc analy-
ses indicated that the interaction effect was due to a signiﬁcantly higher
motor-related activity in patients compared to controls (see Fig. 4A)
during the ﬁrst (T(1,13) = 2.3, p b 0.05), but not during the second ses-
sion (T(1,13) = 0.7, p N 0.5). This pattern was also reﬂected by asigniﬁcant decrease of motor-related activity in patients between the
1st and 2nd sessions (T(1,13) = 5.2, p b 0.001; see also Fig. 2), which
was absent in controls (T(1,13) = 0.5, p N 0.6). For the hippocampal
data (Fig. 4B), in contrast, the post hoc analyses did not show signiﬁcant
differences in novelty-evoked activity between groups for any of the two
sessions (1st session: T(1,13) = –0.5, p N 0.5; 2nd session: T(1,13) = 1.6,
p N 0.1). Within each group, however, direct comparisons between ses-
sions revealed a signiﬁcant increase of novelty-evoked activity in the pa-
tients (T(1,13) = 5.1, p b 0.001), but not in controls (T(1,13) = 0.7,
p N 0.4).
3.3. VBM results
The between-group VBM analysis revealed several clusters of signif-
icantly reducedmagnetization transfer ratio (MTR) in ALSpatients com-
pared to healthy controls (see Fig. 5) indicative of neurodegenerative
processes leading to substance loss/alterations in these regions. The
reduced MTRs were located in the bilateral pre-/postcentral gyrus,
orbitofrontal cortex, hippocampus, thalamus, striatum, and left inferior
frontal gyrus (see Table 6 for MNI-coordinates andmaximum t-values).
To assess a putative relationship between these structural changes
and the patients3 clinical state, we performed regression analyses using
their clinical measures as covariates (ALSFRS-R scores, MRC-Megascores,
disease duration and disease progression rate). In addition, we assessed
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Fig. 3. Functional alterations in novelty processing related to ALS disease-progression. A) Novelty-related activity (“Novels N Non-targets”) from the 1st and 2nd fMRI sessions. Novelty-
related activity was observed across multiple ventral occipital and temporal regions, including the middle/superior occipital, fusiform, lingual and parahippocampal gyri. In addition, sig-
niﬁcant hippocampal novelty-related activations were evident during the 2nd measurement (compare activation maps between the upper and lower rows). B) Direct comparison of
novelty-related activity across sessions. A decrease in hippocampal novelty-related activity occurred from the 1st to the 2nd measurement, which was conﬁrmed by a subsequent ROI-
analysis (see bar plots). C) Correlation of hippocampal ROI-results and the patients3 clinical data. The hippocampal activation-increase showed a negative correlation with the patients3
ALSFRS-R scores for both ROIs.
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MTR-values extracted from spherical ROIs centered at the local activation
maxima of the between-group analysis. Using these two approaches we
did not observe signiﬁcant correlations between the patients3 MTR-
values and their disease state as indexed by any of the clinical measures
employed in our analyses (ALSFRS-R scores, MRC-Megascores, disease
duration and disease progression rate).
3.4. Comparison of fMRI and VBM results
The fMRI part of the current study aimed at investigating how
motor- and novelty-related regions are functionally affected within
the short interval of 3 months of ALS-progression. The volumetric anal-
yses aimed at identifying regions that display alterations of brain tissuein socio-demographically comparable patients at similar disease stages.
Therefore, we superimposed the statistical maps obtained for the func-
tional differences between measurements with those indicating the
structural alterations onto an anatomical template image. By this
meanswe observed a considerable overlap between the structural alter-
ations identiﬁed by the VBM analysis and the functional reduction in
motor-related activity in the course of ALS disease-progression within
the left M1 (illustrated in magenta in Fig. 6). In addition, the motor-
related functional alterations within the striatum and thalamus lay in
close proximity to the structural alterations affecting these regions
(compare red and blue maps in Fig. 6 and activation maxima in
Table 4 and bottom rows of Table 5). Similarly, a comparison between
the functional changes in novelty processing across sessions and our
VBM results revealed an overlap (shown in yellow in Fig. 6), or at
Table 5
Peak activation foci for the comparison of Novels N Non-Targets.
Anatomical structure Hemisphere MNI coordinates (x,y,z) Max.
t-value
FWE-corrected cluster p-value Cluster size
Novels N Non-Targets — 1st session
Fusiform gyrus R 28 –66 –12 9.22 b0.001 1096
PHG R 36 –38 –14 8.23
Lingual gyrus R 24 –76 –6 6.87
Fusiform gyrus L –28 –64 –10 8.75 b0.001 2447
MOG L –32 –98 14 8.48
Lingual gyrus L –26 –76 –8 7.92
PHG L –26 –38 –18 6.81
Anterior lingual gyrus/ precuneus L –10 –54 20 7.74 b0.005 210
Anterior lingual gyrus/ precuneus R 16 –54 18 6.44 b0.05 111
Mog/ SOG R 32 –78 12 7.41 b0.001 1006
Novels N Non-Targets — 2nd session
Fusiform gyrus L –26 –76 –8 15.28 b0.001 11,244
R 26 –74 –8 11.51
Mog/ SOG L –28 –92 22 9.59
R 18 –86 28 14.34
L –34 –70 24 10.86
R 44 –72 22 13.91
Anterior fusiform gyrus L –28 –52 –22 12.03
R 30 –46 –12 9.20
PHG L –34 –36 –12 9.86
R 32 –36 –18 7.85
Anterior lingual gyrus/ precuneus L –10 –44 8 6.32
R 14 –54 18 8.28
Hippocampus L –28 –8 24 9.87
Hippocampus R –32 –12 –18 6.83 b0.001 258
R –32 –20 –22 5.38 b0.05 (SVC) 250
Hippocampus L 26 –24 –14 3.85 b0.05 (SVC) 41
L 28 –14 –22 3.66 b0.05 (SVC) 53
Abbreviations: IPS, intraparietal sulcus; MOG, middle occipital gyrus; PHG, parahippocampal gyrus; SOG, superior occipital gyrus; SVC, small-volume correction.
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tween structural and functional changes in the bilateral hippocampus
(the corresponding activationmaxima are shown in Table 4 and bottom
rows of Table 6).
4. Discussion
Using a longitudinal within-subject design, the current study re-
vealed motor- and memory-related functional alterations emerging
within only 3 months of ALS disease-progression. Importantly, motor
activity decreased during the 3-month interval, while novelty-evoked
hippocampal activity increased at the same time. In addition, theseA
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within-subject comparisons, however, revealed that – in contrast to controls – the patients3 nofunctional changes displayed opposite correlations with clinical
measures: While the motor-evoked activity correlated positively
with the patients3 clinical status (ALSFRS-R and MRC-Megascores), the
hippocampal activations showed an inverse pattern. These results indi-
cate that hippocampal and motor-system lesions emerge at different
disease stages: The relative decrease in motor activity might reﬂect a
breakdown of compensatory mechanisms due to ongoing progressive
neural loss, while the hippocampal activation increase, in contrast, most
likely constitutes the initial built-up of compensatory processes to
overcome dysfunctions typically observed at the beginning of lesions
(Bookheimer et al., 2000; Dickerson and Sperling, 2008; Woodard et al.,
2009). Finally, our additional cross-sectional voxel-based morphometric0
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Fig. 5. Regional atrophy in ALS patients in comparison to controls. Results of the between-group VBM analysis are superimposed on a standard MNI template thresholded at p b 0.001
(uncorrected). Clusters of signiﬁcantly reducedMTR (ALS b controls) were detectedwithin the bilateral precentral gyrus and several subcortical regions, including the bilateral hippocam-
pus, thalamus and striatum (see Table 6 for MNI-coordinates and maximum t-values).
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alterations at the same locations where changes in hemodynamic activity
were observed. Thus, our ﬁndings indicate a close relationship be-
tween functional and structural changes and provide important in-
sights into the temporal dynamics of functional changes during ALS
disease-progression.
4.1. Functional motor-system alterations during ALS disease-progression
In line with most previous studies (Kew et al., 1993; Kollewe et al.,
2011; Konrad et al., 2002; Mohammadi et al., 2011; Schoenfeld et al.,
2005), our ALS patients displayed an increasedmotor activity compared
to controls during the initial measurement. Such increased activity-
levels or recruitments of additional regions have previously been
interpreted as functional compensation or reorganization within the
motor-system. This network showing increased or exclusive motor-
related activity in patients relative to controls comprised regions in
the primary sensorimotor and premotor cortices, supplementary motor
area, dorsal anterior cingulate cortex, cerebellar motor regions and parts
of the striatum and thalamus (Kollewe et al., 2011; Konrad et al., 2002;
Mohammadi et al., 2011; Schoenfeld et al., 2005). These ﬁndings were at-
tributed to an ALS-related cortical hyperexcitability due to the loss of in-
hibitory interneurons (Maekawa et al., 2004), accompanied by reducedTable 6
Peak-values from the voxel-based morphometry controls N ALS patients.
Anatomical structure Hemisphere MNI coordinates (x,y,z)
Striatum R 28 –10
(Putamen) R 28 –2
Thalamus R 24 –28
(Pulvinar/ VLN) R 16 –14
Pre-/ postcentral L –24 –18
Gyrus L –22 –28
L –10 –28
L –38 –10
Thalamus L –20 –18
(Pulvinar/ VLN) L –8 –14
Striatum L –22 0
(Putamen) L –24 4
Precentral gyrus R 18 –24
Hippocampus L –38 –26
Hippocampus R 34 –14
OFC L –14 40
OFC R 20 44
IFG L –36 10
Abbreviations: IFG, inferior frontal gyrus; OFC, orbitofrontal cortex; VLN, ventrolateral nucleusshort-interval intracortical inhibition (Ziemann et al., 1997) and lower
binding rates of the GABA-A receptor ligand ﬂumazenil (Turner et al.,
2005). Importantly, however, at later disease-stages decreased activations
in the sensorimotor and premotor areas have also been described
(Mohammadi et al., 2011; Tessitore et al., 2006). The most plausible
explanation for this pattern of changeswas that after an initial compensa-
tory hyperactivation or recruitment of additional areas, ongoing neuro-
degeneration during disease progression causes a breakdown of the
compensatorymechanisms, ﬁnally resulting in decreased activity levels
compared to earlier (within-subject) measurements or relative to
controls.
Our data fully support this view. For one, the pattern of motor-
related activations closely resembled that described in previous studies
on motor-network functions in ALS (Kollewe et al., 2011; Konrad et al.,
2002; Mohammadi et al., 2011; Schoenfeld et al., 2005) and within this
network we observed a hyperactivation in patients compared to con-
trols during the initial measurement. Beyond that, we observed a rela-
tive (within-subject) reduction in the patients3 motor-related activity
in the left primary sensorimotor cortex and bilateral cerebellum after
only 3 months, which is consistent with the idea that degenerative
changes in motor regions start long before clinical signs are apparent
(Schoenfeld et al., 2005). Further support is provided by the observation
that themagnitude of the activity reductions correlatedwith the patients3Max.
t-value
Corrected cluster p-value Cluster size
12 5.52 b 0.001 460
–8 5.27
14 4.63
10 4.10
30 5.38 b 0.001 521
48 5.08
62 4.07
38 3.96
10 5.26 b 0.001 404
–2 4.80
12 4.47
2 3.85
50 4.15 b 0.05 53
–2 4.84 b 0.005 83
–20 4.15 b 0.05 58
–14 4.95 b 0.01 81
–12 3.89 b 0.05 55
28 5.86 b 0.001 131
of the thalamus.
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Fig. 6.Overlap between structural and functional alterations. Results from the VBM analysis (illustrated in red) and for changes inmotor- (blue) and novelty-related (green) activity were
superimposed onto an anatomical template image. Direct overlap of functional motor-related (fMRI) and structural (VBM) alterations is shown inmagenta, while overlap between func-
tional novelty-related and structural alterations is illustrated in yellow.
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ease stage) were accompanied by more pronounced decreases in motor
activity during the 3-month interval. Taken together, these data corrobo-
rate the idea of a continuously changing motor-network function in ALS,
indicating that activity changes in the motor-system caused by progres-
sive neurodegeneration are most pronounced at early stages of the dis-
ease, while the breakdown of functional compensatory processes occurs
later.4.2. Functional changes in the hippocampus during ALS disease-progression
Traditionally considered as a neurodegenerative disease selectively
affecting themotor-system, ALS is now conceptualized as amultisystem
disorder also affecting other cognitive domains.While only a proportion
of ALS patients develop actual clinical signs of frontotemporal dementia
(Lomen-Hoerth et al., 2002), milder cognitive and behavioral im-
pairments occur in up to 50% of the patients (Hammer et al., 2011;
Lomen-Hoerth et al., 2002; Phukan et al., 2012; Raaphorst et al.,
2010). In agreement with these data, we observed cognitive deﬁcits
inmore than 40% of our patients – predominantly but not exclusively in
the form of executive dysfunctions. Moreover, comparable to earlier
studies (Hammer et al., 2011; Mantovan et al., 2003; Phukan et al.,
2012; Raaphorst et al., 2010), 14–21% also exhibited deﬁcits in the
memory domain.
However, although memory dysfunctions and concordant hippo-
campal neurodegeneration (Anderson et al., 1995; Grosskreutz et al.,
2006; Kato et al., 1997; Neumann et al., 2006; Takeda et al., 2009;
Takeda et al., 2007; Wightman et al., 1992) have repeatedly been de-
scribed, no study so far directly addressed a potential functional affec-
tion of the hippocampus in ALS. Particularly, it is not clear how the
hippocampal lesions evolve over time and how they translate into he-
modynamic activity changes. To bridge this gap, the current task-
design comprised the presentation of task-irrelevant novel stimuli
shown to elicit robust hippocampal activations (Bunzeck and Duzel,
2006; Stoppel et al., 2009). Beyond this robust activation of the hippo-
campus, the novelty-processing network activated by this task-design
comprised occipital vision-related (fusiform and lingual gyrus) and
temporal memory-related (parahippocampal gyrus and hippocampus)
regions (Bunzeck and Duzel, 2006; Stoppel et al., 2009), which showed
no overlap to the classical motor-network described above. In contrast
to the activity in this motor network – which was initially higher than
in controls and decreased in the 3-month interval− the hippocampal
activations were higher in the second measurement and not different
from that in healthy controls. Such increased hippocampal responses
have previously been described in mild cognitive impairment and
interpreted as a compensatory recruitment of neural resources to
overcome early disease stage dysfunctions (Bookheimer et al., 2000;
Dickerson and Sperling, 2008;Woodard et al., 2009). Moreover, similar
hyperactivations across different brain areas indicating fresh lesions
were observed in other early-stage neurodegenerative disorders suchas pre-manifest Parkinsonism or Huntington3s disease (Buhmann et al.,
2005; Kloppel et al., 2009). Given that most of our patients showed no
or only slight memory impairments, the hippocampal hyperactivity in
the second measurement might indeed reﬂect such compensation pro-
cesses to overcome early lesions (Agosta et al., 2010; Anderson et al.,
1995; Takeda et al., 2009; Tsermentseli et al., 2012). Consequently, the
present results suggest that hippocampal dysfunctions develop at later
disease stages than the motor-system lesions. This is further supported
by the inverse correlation between the hippocampal activity increase
and the patients3 ALSFRS-R scores (i.e. a more pronounced enhancement
was evident at later stages of the disease).
In this context it has to be noted that an increase of hippocampal
novelty-related activity only was observed in the patient group, while
no signiﬁcant differences were observed in comparison to controls or
within the control group across the 3 months. This is most likely due
to the fact that the relative increase of hemodynamic activity in patients
is a rather small effect and therefore not signiﬁcantly different from the
stable activity level of controls (that probably lies in between the activa-
tion level of the ﬁrst and second measurements in ALS patients). This
points out to the importance of longitudinal designs for studying
disease-related neurodegenerative changes and provides a convincing
explanationwhy previous studies that compared ALS patientswith con-
trols did not ﬁnd hemodynamic activity-differences in the hippocam-
pus. Strong decreases of activity in this region are certainly present at
later stages of the disease, while early stages seem to be rather indexed
by a compensatory activity-increase as observed in the present study.4.3. Structural alterations in ALS patients relative to controls
Several studies described structural neurodegenerative alterations in
ALS not onlywithinmotor areas, but also acrossmultiple frontotemporal,
limbic or subcortical structures (Agosta et al., 2010; Anderson et al., 1995;
Grosskreutz et al., 2006; Kato et al., 1997; Neumann et al., 2006; Takeda
et al., 2009; Tsermentseli et al., 2012; Wightman et al., 1992). As for the
functional results, the pattern of changes was quite inconsistent across
studies, probably due to differences in the disease stages of the patient
populations. In addition, early-stage neurodegeneration is primarily
indexed bymicrostructural alterations as e.g. intra- or extracellularma-
trix alterations, gliosis and axonal density-changes (Douaud et al., 2013;
Khandelwal et al., 2011; Robberecht and Philips, 2013), which are not
well detected by VBM based on T1-weighted brain volumes (Kabani
et al., 2002; van der Flier et al., 2002). To address this problem, we
employed magnetization transfer imaging, which detects not only vol-
umetric changes (as e.g. neuronal loss or tissue shrinkage) but also mi-
crostructural alterations dependent of tissue myelination, axonal
density, or gliosis (Grossman et al., 1994; Hanyu et al., 2000; van
Waesberghe et al., 1999; Wolff and Balaban, 1994). This analysis is
therefore sensitive to lesions present at early stages of neurodegenera-
tion, as it has previously been demonstrated for several other diseases
(Eckert et al., 2004; Kiefer et al., 2009; Perez-Torres et al., 2014; Ridha
288 C.M. Stoppel et al. / NeuroImage: Clinical 5 (2014) 277–290et al., 2007). Using a cross-sectional design, we thereby identiﬁed
MTR-reductions in most previously described regions evident in T1-
based volumetric analyses, including the precentral gyrus, frontal/
orbitofrontal cortex, hippocampus, thalamus, and striatum. For most
of these regions, however, results were inconsistent across previous in-
vestigations on T1-weighted images. Beyond that, most previous stud-
ies employing MTR to investigate structural differences related to ALS
only focused on changes within the corticospinal tract (da Rocha et al.,
2004; El Mendili et al., 2014; Kato et al., 1997; Tanabe et al., 1998;
Verstraete et al., 2014) and to date only two studies analyzed MTR on
whole-brain data in ALS using a ROI-based approach (Cosottini et al.,
2011) or voxel-based volumetric analyses (Cosottini et al., 2013). These
two studies also revealed changes inMTR across severalmotor/premotor
and extra-motor regions, which is in good agreement with the current
results. Importantly, beyond these previously described differences at
cortical sites our analyses also revealed MTR reductions across several
subcortical areas (hippocampus, thalamus and striatum).While previous
imaging analyses (which mainly relied on T1-weighted brain volumes)
failed to demonstrate ALS-related structural changes in these regions,
histopathological investigations did show their affection during the
course of the disease. Thus, our current results suggest that whole-
brain VBM analyses based onmagnetization transfer imaging are poten-
tially more sensitive to early structural damage in rapid progressive
neurodegenerative disorders.
4.4. Relationship between structural and functional changes in ALS
The fMRI part of the current study sought to investigate howmotor-
and novelty related regions are functionally affectedwithin the short in-
terval of 3 months of ALS progression, while the volumetric analyses
aimed at identifying regions showing alterations of brain tissue in an-
other group of socio-demographically comparable patients at similar
disease stages using a cross-sectional design. Although the fMRI study
was performed in a different patient sample than the VBM analysis,
we sought to look roughly for commonalities between the functional
alterations during disease progression and the structural changes
obtained by means of our cross-sectional design. For this aim, we
superimposed the statistical maps obtained for the functional differ-
ences between fMRI measurements from the ﬁrst sample with those
indexing the ALS related tissue differences from the larger second sam-
ple. Despite this rather coarse approach we observed a high degree of
overlap between the disease-related changes in hemodynamic activity
and those regions that are subject to structural damage (see Fig. 6).
This was the case not only for functional alterations in motor regions,
but also for those in the limbic system. Being aware that structural
changes are the result of neural degeneration on a longer time scale,
while hemodynamic measures reﬂect changes on a much shorter one,
the high degree of overlap indicates that in ALS the functional changes
occur in the same regions that are subject to structural damage.
Given that our structural and functional data were acquired using
two separate cohorts on two different scanners, we acknowledge that
no hard conclusions should be drawn despite the high degree of overlap
between the structural and functional results. Thus, future within-
subject comparisons clarifying to which extent the structural and func-
tional changes in fact overlap are mandatory. Despite this fact, we nev-
ertheless believe that our results are of rather high reliability, since the
high degree of spatial overlap was achieved not because, but although
the data were acquired under conditions of rather high variability (dif-
ferent scanners/ different cohorts).
4.5. Conclusions
The current longitudinal study revealed functional alterations in
motor- and memory-related regions within only 3 months of ALS
disease-progression. Moreover, we observed ALS related tissue differ-
ences at the same anatomical locations in a second patient samplestudied cross-sectionally. These results indicate that ALS is a multisys-
tem disorder, in which the hippocampus also is affected. Moreover,
the dynamics of the observed fMRI changes suggest that the functional
affection of motor- and memory-related regions emerges at different
stages of ALS: While the motor-system lesions develop rather early,
the hippocampal dysfunctions arise later in the course of the disease.
The knowledge of the progression-related dynamicswithin different
functional systems (motor, memory etc.) during the course of ALS is es-
sential for understanding the nature and development of the disease
and provides a tremendous potential for fMRI to become a diagnostic
tool in the future. The present data highlight the value of longitudinal
fMRI investigations designed to speciﬁcally address particular functional
alterations emerging during the progression of ALS and signify their po-
tential usefulness as a diagnostic tool for neurodegenerative disorders.
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